F-18 FDG PET-CT in patients with recurrent glioma: Comparison with contrast enhanced MRI

Wallner, 1989, Patterns of failure following treatment for glioblastoma and anaplastic astrocytoma, Int J Radiol Oncol Biol Phys, 16, 140, 10.1016/0360-3016(89)90941-3 Burger, 1986, Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment, Semin Oncol, 13, 16 Mikhael, 1978, Radiation necrosis of the brain: correlation between, computed tomography, pathology and dose distribution, J Comput Assist Tomogr, 2, 71, 10.1097/00004728-197801000-00011 Van Dellen, 1978, Failure of computerized tomography to differentiate between radiation necrosis and cerebral tumour, S Afr Med J, 53, 171 Price, 2007, The role of advanced MR imaging in understanding brain tumour pathology, Br J Neurosurg, 21, 562, 10.1080/02688690701700935 Dooms, 1986, Brain radiation lesions: MR imaging, Radiology, 158, 149, 10.1148/radiology.158.1.3940373 Delbeke, 1995, Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low grade from high-grade brain tumors with PET, Radiology, 195, 47, 10.1148/radiology.195.1.7892494 Roelcke, 1995, Alteration of blood–brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET, J Neurol Sci, 132, 20, 10.1016/0022-510X(95)00117-K Kaschten, 1998, Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine, J Nucl Med, 39, 778 Wong, 2002, Positron emission tomography imaging of brain tumors, Neuroimaging Clin N Am, 12, 615, 10.1016/S1052-5149(02)00033-3 Ricci, 1998, Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography, Am J Neuroradiol, 9, 407 Asensio, 1998, The role of PET-FDG in questionable diagnosis of relapse in the presence of radionecrosis of brain tumors, Rev Neurol, 27, 447 Di Chiro, 1982, Glucose utilization of cerebral gliomas measured by (18F)fluorodeoxyglucose and positron emission tomography, Neurology, 32, 1323, 10.1212/WNL.32.12.1323 Belohlavek, 2002, The diagnostics of recurrent gliomas using FDG-PET: still questionable?, Nucl Med Rev Cent East Eur, 5, 127 Chen, 2004, Value of 18F-FDG PET imaging in diagnosing tumor residue of intracranial glioma after surgery and radiotherapy, Ai Zheng, 23, 1210 Ostergaard, 1999, Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood–brain barrier permeability following dexamethasone treatment in patients with brain tumors, J Neurosurg, 90, 300, 10.3171/jns.1999.90.2.0300 Kaye, 2001 Wang, 2006, FDG-PET on irradiated brain tumor: ten years summary, Acta Radiol, 47, 85, 10.1080/02841850500335101 Devaux, 1993, Resection, biopsy and survival in malignant glioma, a retrospective study of clinical parameters, therapy and outcomes, J Neurosurg, 78, 767, 10.3171/jns.1993.78.5.0767 Okamoto, 2004, Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas, Acta Neuropathol, 108, 49, 10.1007/s00401-004-0861-z